Author:
Viégas Célia Maria Pais,Morais Diego Chaves Rezende,de Araujo Carlos Manoel Mendonça
Publisher
Springer International Publishing
Reference40 articles.
1. Locally Advanced Squamous Carcinoma of the Head Neck. Union for International Cancer Control. 2014 Review of Cancer Medicines on the WHO List of Essential Medicines. Available in: www.who.int/selection_medicines/committees/expert/20/applications/HeadNeck.pdf . Last access: 15/09/2016.
2. American Cancer Society. Cancer Facts and Figures 2016. Atlanta: American Cancer Society; 2016.
3. Brasil MS. Estimativa 2016: incidência de câncer no Brasil/Instituto Nacional de Câncer José Alencar Gomes da Silva—Rio de Janeiro: INCA, 2015.
4. Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, Adab F, Jefferies SJ, Scrase C, Yap BK, A'Hern RP, Sydenham MA, Emson M, Hall E, PARSPORT Trial Management Group. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011;12(2):127–36.
5. Gupta T, Agarwal J, Jain S, Phurailatpam R, Kannan S, Ghosh-Laskar S, Murthy V, Budrukkar A, Dinshaw K, Prabhash K, Chaturvedi P, D'Cruz A. Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial. Radiother Oncol. 2012;104(3):343–8.